Skip to main content
Medica logo

Medica — Investor Relations & Filings

Ticker · MDC ISIN · IT0005460149 LEI · 815600FE16FA9F3E2296 XMIL Manufacturing
Open in API
Filings indexed 114 across all filing types
Latest filing 2023-04-28 AGM Information
Country IT Italy
Listing XMIL MDC

About Medica

https://www.medica.it/

Medica S.p.A. is a company specializing in advanced purification technologies. Its core business is the development and production of products for blood purification, with applications in dialysis, Continuous Renal Replacement Therapy (CRRT), and apheresis. The company's medical product portfolio includes polysulfone membranes, dialysis filters, hemofilters, and blood lines. It has expanded its expertise into other medical fields such as cardiology, oncology surgery, organ transplantation, urology, and gastroenterology. Leveraging its filtration know-how, Medica also operates a water purification division that produces hollow fiber membranes. Additionally, the company offers turnkey solutions for the biomedical sector, providing vertically integrated services from research and development to manufacturing, industrial automation, and regulatory management.

Recent filings

Filing Released Lang Actions
Medica SpA - ordinary shareholders meeting of 28 april 2023
AGM Information Classification · 99% confidence The document is explicitly titled a 'Press release' and announces several key corporate actions taken during an 'ordinary shareholders' meeting' held on April 28, 2023. The actions include: approval of the Financial Statement as of 31 December 2022, appointment of independent auditors (EY S.p.A.), and determination of Board remuneration. The text concludes by stating that copies of the 2022 financial statements and consolidated financial statements 'can be consulted' and are available on the company website. This structure—a brief announcement summarizing key decisions made at a shareholder meeting and directing readers to the full reports—is characteristic of an announcement related to the Annual General Meeting (AGM). While it mentions financial statements (which could suggest 10-K or ER), the primary context is the shareholder meeting approvals. Since the document is short and announces the availability of reports rather than being the full report itself, and it deals with AGM outcomes, AGM-R (AGM Information) is the most appropriate classification, as it covers materials shared during the AGM.
2023-04-28 Italian
Medica SpA - assemblea ordinaria degli azionisti del 28 aprile 2023
AGM Information Classification · 99% confidence The document is titled "Comunicato stampa" (Press Release) and announces several key corporate actions taken during the Shareholders' Meeting held on April 28, 2023. Specifically, it mentions the approval of the financial statements (Bilancio d'esercizio) for the year ended December 31, 2022, the approval of the allocation of profit, the acknowledgment of the consolidated financial statements, the appointment of the statutory auditor (EY S.p.A.), and the determination of the Board of Directors' compensation. Since this is a press release announcing the results of the Annual General Meeting (AGM) and related approvals, it strongly aligns with the 'AGM Information' category (AGM-R). Although it discusses financial results, the primary function of this specific document is reporting the outcomes of the shareholder assembly, not providing the full financial report (10-K or IR) or just the initial earnings highlights (ER). Given the content focuses on AGM decisions, AGM-R is the most appropriate classification.
2023-04-28 Italian
Medica SpA - substantial change of significant shareholders
Major Shareholding Notification Classification · 98% confidence The document is explicitly titled "Comunicato stampa" (Press Release) and announces a "SUBSTANTIAL CHANGE OF SIGNIFICANT SHAREHOLDERS" based on Article 17 of the Euronext Growth Milan Issuer Regulation. It details that Azimut Investments S.A. crossed the 5% materiality threshold. This type of mandatory disclosure regarding changes in significant share ownership directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is a press release, the core content is the notification of a change in ownership percentage, which is more specific than a general Regulatory Filing (RNS).
2023-04-28 English
Medica SpA - cambiamento sostanziale degli azionisti significativi
Major Shareholding Notification Classification · 98% confidence The document is explicitly titled "Comunicato stampa" (Press Release) and announces a "CAMBIAMENTO SOSTANZIALE DEGLI AZIONISTI SIGNIFICATIVI" (Substantial Change in Significant Shareholders) based on Article 17 of the Euronext Growth Milan Issuer Regulations. This communication details that Azimut Investments S.A. crossed the 5% ownership threshold. This type of filing, which reports changes in major shareholdings, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is a press release, the core content is the mandatory disclosure of a significant ownership change, making MRQ the most specific classification over a general Regulatory Filing (RNS). The document length (4081 chars) is not short enough to trigger the RPA/RNS rule based on merely announcing an attached report; this document *is* the announcement itself.
2023-04-28 Italian
Medica SpA - Avviso di convocazione di Assemblea Ordinaria
AGM Information Classification · 100% confidence The document is titled "AVVISO DI CONVOCAZIONE DI ASSEMBLEA ORDINARIA MEDICA SPA" (Notice of Call for Ordinary Shareholders' Meeting of Medica S.p.A.). It details the date (April 28, 2023), time, location, and the specific agenda items (ORDINE DEL GIORNO) for the meeting, which include the approval of the 2022 financial statements and the appointment of auditors. This content directly relates to the formal procedures and materials associated with an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R).
2023-04-13 Italian
Medica SpA - SIMEST (CDP Group) enters the share capital of Medica USA Inc
Capital/Financing Update Classification · 98% confidence The document text announces a specific corporate transaction: SIMEST (CDP Group) entering the share capital of Medica USA Inc. This involves an investment, acquisition of a stake, and a shareholder loan agreement. This type of activity—fundraising, financing, or capital structure change involving external parties—fits the definition of 'Capital/Financing Update' (CAP). It is not an earnings release (ER), an annual report (10-K), or a general regulatory filing (RNS), as it describes a concrete financing event.
2023-04-05 Italian

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.